Management of Asymptomatic Wolff-Parkinson-White Pattern by Pediatric Electrophysiologists.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
10 2019
Historique:
received: 14 03 2019
revised: 20 05 2019
accepted: 22 05 2019
pubmed: 27 6 2019
medline: 26 5 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

To determine the present-day approach of pediatric cardiac electrophysiologists to asymptomatic Wolff-Parkinson-White (WPW) pattern and to contrast to both published consensus statements and a similar survey. A questionnaire was sent to 266 Pediatric and Congenital Electrophysiology Society physician members in 25 countries; 21 questions from the 2003 survey were repeated, with new questions added regarding risk stratification and decision making. We received 113 responses from 13 countries, with responders having extensive electrophysiology experience (median 15 years [IQR 8.5-25 years]). Only 12 (11%) believed that intermittent pre-excitation and 37 (33%) that sudden loss of pre-excitation on exercise test were sufficient evidence of accessory pathway safety to avoid an invasive electrophysiology study. Optimal weight for electrophysiology study was 20 kg (IQR 18-22.5 kg), and 61% and 58% would then ablate all right-sided or left-sided accessory pathways, respectively, regardless of electrophysiological properties, whereas only 23% would ablate all septal accessory pathways (P < .001). Compared with 2003, respondents were more likely to consider inducible arrhythmia (77% vs 26%, P < .001) as sufficient indication alone for ablation. In the context of recent literature regarding the reliability of risk-stratification tools, most operators are now performing electrophysiology study for asymptomatic Wolff-Parkinson-White regardless of noninvasive findings. Many will then proceed to default ablation of all accessory pathways distant from critical conduction structures.

Identifiants

pubmed: 31235382
pii: S0022-3476(19)30675-4
doi: 10.1016/j.jpeds.2019.05.058
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-95.e1

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Henry Chubb (H)

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, CA. Electronic address: mhchubb@stanford.edu.

Robert M Campbell (RM)

Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA.

Kara S Motonaga (KS)

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, CA.

Scott R Ceresnak (SR)

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, CA.

Anne M Dubin (AM)

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH